Impact of interferon-ribavirin treatment on hepatitis C virus (HCV) protease quasispecies diversity in HIV- and HCV-coinfected patients

por Chary, Aarthi, Winters, Mark A., Kottilil, Shyam, Murphy, Alison A., Polis, Michael A., Holodniy, Mark
Publicado em 2010

Hepatitis C-Associated Mixed Cryoglobulinemic Vasculitis Induces Differential Gene Expression in Peripheral Mononuclear Cells

por Sidharthan, Sreetha, Kim, Cheol-Woo, Murphy, Alison A., Zhang, Xiaozhen, Yang, Jun, Lempicki, Richard A., Sneller, Michael C., Kottilil, Shyam
Publicado em 2014

Proteome-wide Anti-HCV and Anti-HIV Antibody Profiling for Predicting and Monitoring Response to HCV Treatment in HIV Co-infected Patients

por Burbelo, Peter D., Kovacs, Joseph A., Ching, Kathryn H., Issa, Alexandra T., Iadarola, Michael J., Murphy, Alison A, Schlaak, Joerg F., Masur, Henry, Polis, Michael A., Kottilil, Shyam
Publicado em 2010

Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy

por Murphy, Alison A., Herrmann, Eva, Osinusi, Anu O., Wu, Lynn, Sachau, William, Lempicki, Richard A., Yang, Jun, Chung, Tei L., Wood, Brad J., Haagmans, Bart L., Kottilil, Shyam, Polis, Michael A.
Publicado em 2011